Amarantus Bioscience Holdings Inc (OTCQB:AMBS)
| 0.042 Data as of 2:46pm ET |  -0.0019 / -4.33%Today’s Change | 0.00 Today|||52-Week Range 0.20 | -68.18% Year-to-Date |
Latest AMBS News | Press Releases
Today’s Trading
| Previous close | 0.04 |
| Today’s open | 0.04 |
| Day’s range | 0.04 - 0.05 |
| Volume | 1,074,724 |
| Average volume (3 months) | 3,575,540 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 2:46pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -19,900.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 31.81 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $223.6K |
| Annual profit (last year) | -$4.4M |
| Net profit margin | -1,985.84% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Gerald E. Commissiong |
Chief Financial Officer, Secretary & Treasurer Marc E. Faerber, CPA |
Corporate headquarters Sunnyvale, California |
Forecasts
